Literature DB >> 26439966

Role of inflammation and apoptosis in multiple sclerosis: Comparative analysis between the periphery and the central nervous system.

Beatrice Macchi1, Francesca Marino-Merlo2, Ugo Nocentini3, Valerio Pisani4, Salvatore Cuzzocrea5, Sandro Grelli6, Antonio Mastino7.   

Abstract

Multiple sclerosis (MS) is a complex, multifactorial disease associated with damage to the axonal myelin sheaths and neuronal degeneration. The pathognomonic event in MS is oligodendrocyte loss accompanied by axonal damage, blood-brain barrier leakage, inflammation and infiltration of immune cells. The etiopathogenesis of MS is far from being elucidated. However, increasing evidence suggests that the inflammatory and apoptotic responses, occurring in patients either at the peripheral level or the central nervous system (CNS), can play a role. In this review, we give a comprehensive picture of general aspects of inflammation and apoptosis in MS, with special emphasis on the until now not well highlighted possible links between phenomena relevant to these aspects occurring in either the periphery or in the CNS during MS.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Inflammation; Multiple sclerosis; Targeted therapy

Mesh:

Year:  2015        PMID: 26439966     DOI: 10.1016/j.jneuroim.2015.08.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

Review 1.  Apoptosis and apoptotic body: disease message and therapeutic target potentials.

Authors:  Xuebo Xu; Yueyang Lai; Zi-Chun Hua
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840

2.  Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.

Authors:  Giacomo Lazzarino; Angela M Amorini; Axel Petzold; Claudio Gasperini; Serena Ruggieri; Maria Esmeralda Quartuccio; Giuseppe Lazzarino; Enrico Di Stasio; Barbara Tavazzi
Journal:  Mol Neurobiol       Date:  2016-11-08       Impact factor: 5.590

3.  Conjunctival impression cytology and tear film parameters in patients with multiple sclerosis.

Authors:  Selman Belviranli; Pembe Oltulu; Ali Ulvi Uca; Ali Osman Gundogan; Enver Mirza; Mustafa Altas; Nazli Turk; Refik Oltulu
Journal:  Int Ophthalmol       Date:  2021-10-01       Impact factor: 2.031

4.  Isolation and Quantification of Blood Apoptotic Bodies, a Non-invasive Tool to Evaluate Apoptosis in Patients with Ischemic Stroke and Neurodegenerative Diseases.

Authors:  Gemma Serrano-Heras; Inmaculada Díaz-Maroto; Beatriz Castro-Robles; Blanca Carrión; Ana B Perona-Moratalla; Julia Gracia; Sandra Arteaga; Francisco Hernández-Fernández; Jorge García-García; Oscar Ayo-Martín; Tomás Segura
Journal:  Biol Proced Online       Date:  2020-08-01       Impact factor: 3.244

5.  Creatine Enhances Mitochondrial-Mediated Oligodendrocyte Survival After Demyelinating Injury.

Authors:  Kelly A Chamberlain; Kristen S Chapey; Sonia E Nanescu; Jeffrey K Huang
Journal:  J Neurosci       Date:  2017-01-09       Impact factor: 6.167

6.  Genetic polymorphisms and epigenetic regulation of survivin encoding gene, BIRC5, in multiple sclerosis patients.

Authors:  Dariush Rahban; Forogh Mohammadi; Mehdi Alidadi; Taha Ghantabpour; Pedram Abbasi Ghasem Kheyli; Majid Ahmadi
Journal:  BMC Immunol       Date:  2019-08-22       Impact factor: 3.615

7.  Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies.

Authors:  Josip Sremec; Sanja Tomasović; Nada Tomić Sremec; Alan Šućur; Jelena Košćak Lukač; Koraljka Bačić Baronica; Danka Grčević; Nataša Kovačić
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

8.  IFP35 family proteins promote neuroinflammation and multiple sclerosis.

Authors:  Xizhong Jing; Yongjie Yao; Danning Wu; Hao Hong; Xu Feng; Na Xu; Yingfang Liu; Huanhuan Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-10       Impact factor: 11.205

9.  Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?

Authors:  Beatrice Macchi; Antonio Mastino
Journal:  Neural Regen Res       Date:  2016-05       Impact factor: 5.135

Review 10.  Selective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.

Authors:  Valentina Pegoretti; Wia Baron; Jon D Laman; Ulrich L M Eisel
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.